跳至主要内容
临床试验/CTRI/2020/05/025361
CTRI/2020/05/025361尚未招募2 期

Clinical Study to Compare Safety & Efficacy of Unani Formulation , Ushq (Dorema ammoniacum) & Sirka ( Vinegar) With Terbinafine in Patients of Quba ( Dermatophytosis, Ringworm)

Central Council for Research in Unani Medicine New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically diagnosed patients of Quba (confirmed on Direct Microscopy).
  • -Irrespective of gender
  • -Patients in the age group of 15 to 65 years.
  • -Patients ready to participate in the study and ready to follow in instructions & voluntary written consent

排除标准

  • -Patients below and above the age of 15 and 65 years respectively.
  • -Patient suffering from concomitant diseases like psoriasis & Eczema.
  • -Patient suffering from severe systemic and metabolic diseases.
  • -Diabetic, HTN, COPD, Thyrotoxicosis etc and HIV patient.
  • -Impaired organ functions
  • -Patients with any trauma and accidents
  • -Pregnant & Lactating Women.
  • -Any of them not covered under inclusive criteria

研究者

发起方
Central Council for Research in Unani Medicine New Delhi

相似试验